Target intelligence / Profile preview

MT-ND5 pseudogene 30 (MTND5P30)

Target
MTND5P30
Molecular classification
Other (pseudogene)
01

Overview

MT-ND5 pseudogene 30 (MTND5P30) is classified as a pseudogene, which is a DNA sequence resembling a functional gene but lacking the capability to encode a functional protein[2][4][6]. It is a nuclear DNA sequence related to the mitochondrial gene MT-ND5, which encodes a subunit of Complex I, a key enzyme in mitochondrial oxidative phosphorylation[1][3][5]. However, pseudogenes such as MTND5P30 do not contribute to the function of Complex I and are not therapeutic targets, disease-related genes, or functional biomarkers[2][5][6]. MTND5P30 is often referenced in genome databases (NCBI Gene ID: 100873266, HGNC: 42292) strictly as a pseudogene[2][6]. There is no evidence in the literature or databases of a protein product, involvement in biological pathways, disease association, drug targeting, or relevance as a biomarker[2][4][6]. Reports of pseudogenes for mitochondrial genes support their existence in nuclear DNA but emphasize that mutations or expression of these pseudogenes do not produce functional mitochondrial proteins, nor do they compensate for mitochondrial gene defects[5]. MT-ND5P30 is sometimes erroneously treated as a potential functional target, but it is not considered a therapeutic target or relevant in the context of receptor, enzyme, transporter, or drug activity research[2][5][6]. There are no known drugs or mechanisms acting on this pseudogene. If encountered in target lists for therapeutic discovery, it should be flagged as a non-functional pseudogene, not as a druggable protein or receptor[2][6].

Other names
MTND5P30mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 30

Beyond the preview

Go deeper on MT-ND5 pseudogene 30 (MTND5P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND5 pseudogene 30 (MTND5P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call